Carolyn C Gotay1, Sean Ransom, Ian S Pagano. 1. Prevention and Control Program, Cancer Research Center of Hawaii, University of Hawaii at Manoa, Honolulu, Hawaii 96822, USA. cgotay@crch.hawaii.edu
Abstract
BACKGROUND: Cancer survivors may develop additional cancers after their first diagnosis, but to the authors' knowledge the quality of life (QOL) consequences of a second cancer are not known. The current study assessed QOL and its correlates after a second cancer diagnosis. METHODS: QOL was compared between 487 survivors of second-order and higher-order primary cancer diagnoses, and a matched group of 589 survivors of a single cancer diagnosis. Outcome measures included standardized questionnaires that assessed depressive symptoms, perceived stress, vitality, post-traumatic growth, existential well-being, sexual adjustment, and global QOL. RESULTS: Survivors of multiple primary cancer diagnoses had significantly lower global QOL (t (792) = 5.42; P < .001), vitality (Student t test [t] (794) = 2.41; P < .01), and existential well-being (t (775) = 2.78; P < .01), and higher intrusive stress symptoms (t (775) = -1.93; P < .05). Controlling for demographic, medical, and trait-like psychosocial characteristics (eg, optimism and resilience), having multiple primary cancer diagnoses explained small, although significant, variances in global QOL (coefficient of determination [R(2)] = .04; P < .001), vitality (R(2) = .01; P < .05), and existential well-being (R(2) = .01; P < .05), with patients in the multiple primary cancer group faring worse on all of these measures. CONCLUSIONS: The results of the current study suggest that the typical survivor of multiple primary cancers experiences modest but lasting QOL deficits.
BACKGROUND:Cancer survivors may develop additional cancers after their first diagnosis, but to the authors' knowledge the quality of life (QOL) consequences of a second cancer are not known. The current study assessed QOL and its correlates after a second cancer diagnosis. METHODS: QOL was compared between 487 survivors of second-order and higher-order primary cancer diagnoses, and a matched group of 589 survivors of a single cancer diagnosis. Outcome measures included standardized questionnaires that assessed depressive symptoms, perceived stress, vitality, post-traumatic growth, existential well-being, sexual adjustment, and global QOL. RESULTS: Survivors of multiple primary cancer diagnoses had significantly lower global QOL (t (792) = 5.42; P < .001), vitality (Student t test [t] (794) = 2.41; P < .01), and existential well-being (t (775) = 2.78; P < .01), and higher intrusive stress symptoms (t (775) = -1.93; P < .05). Controlling for demographic, medical, and trait-like psychosocial characteristics (eg, optimism and resilience), having multiple primary cancer diagnoses explained small, although significant, variances in global QOL (coefficient of determination [R(2)] = .04; P < .001), vitality (R(2) = .01; P < .05), and existential well-being (R(2) = .01; P < .05), with patients in the multiple primary cancer group faring worse on all of these measures. CONCLUSIONS: The results of the current study suggest that the typical survivor of multiple primary cancers experiences modest but lasting QOL deficits.
Authors: M B Hannouf; E Winquist; S M Mahmud; M Brackstone; S Sarma; G Rodrigues; P Rogan; J S Hoch; G S Zaric Journal: Pharmacogenomics J Date: 2016-03-29 Impact factor: 3.550
Authors: Zeng Jie Ye; Mu Zi Liang; Hao Wei Zhang; Peng Fei Li; Xue Ren Ouyang; Yuan Liang Yu; Mei Ling Liu; Hong Zhong Qiu Journal: Qual Life Res Date: 2018-03-22 Impact factor: 4.147
Authors: Kara N Maxwell; Brandon M Wenz; Abha Kulkarni; Bradley Wubbenhorst; Kurt D'Andrea; Benita Weathers; Noah Goodman; Joseph Vijai; Jenna Lilyquist; Steven N Hart; Thomas P Slavin; Kasmintan A Schrader; Vignesh Ravichandran; Tinu Thomas; Chunling Hu; Mark E Robson; Paolo Peterlongo; Bernardo Bonanni; James M Ford; Judy E Garber; Susan L Neuhausen; Payal D Shah; Angela R Bradbury; Angela M DeMichele; Kenneth Offit; Jeffrey N Weitzel; Fergus J Couch; Susan M Domchek; Katherine L Nathanson Journal: JCO Precis Oncol Date: 2020-08-19
Authors: Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay Journal: J Womens Health (Larchmt) Date: 2012-10-17 Impact factor: 2.681
Authors: Kerri M Clough-Gorr; Soe Soe Thwin; Jaclyn L F Bosco; Rebecca A Silliman; Diana S M Buist; Pamala A Pawloski; Virginia P Quinn; Marianne N Prout Journal: Cancer Date: 2012-12-26 Impact factor: 6.860
Authors: Melissa S Y Thong; Floortje Mols; Jan-Willem W Coebergh; Jan A Roukema; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2009-06-26 Impact factor: 4.442